ALEXANDRIA Study Egypt

Trial Identifier:	D133FR00138
Sponsor:	AstraZeneca
NCTID::	NCT03583463
Start Date:	October 2018
Primary Completion Date:	January 2021
Condition:	Breast Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Egypt	Alexandria, Egypt
Egypt	Cairo, Egypt
Egypt	El Gharbia, Egypt
Egypt	El Menofia, Egypt
Egypt	Gharbia, Egypt
Egypt	Giza, Egypt
Egypt	Luxur, Egypt
Egypt	Zagazig, Egypt

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.